SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,528,584 | +6.5% | 12,610 | +0.6% | 0.02% | +10.5% |
| Q2 2023 | $1,435,852 | -9.3% | 12,538 | +9.1% | 0.02% | -17.4% |
| Q1 2023 | $1,583,253 | +7.2% | 11,487 | +0.8% | 0.02% | -4.2% |
| Q4 2022 | $1,476,435 | +34.7% | 11,394 | +14.9% | 0.02% | +14.3% |
| Q3 2022 | $1,096,000 | +48.3% | 9,917 | +0.5% | 0.02% | +40.0% |
| Q2 2022 | $739,000 | +0.8% | 9,863 | +5.1% | 0.02% | +25.0% |
| Q1 2022 | $733,000 | -12.7% | 9,384 | +0.6% | 0.01% | -7.7% |
| Q4 2021 | $840,000 | +6.1% | 9,332 | +9.0% | 0.01% | -13.3% |
| Q3 2021 | $792,000 | +14.5% | 8,560 | -3.9% | 0.02% | +15.4% |
| Q2 2021 | $692,000 | +18.9% | 8,905 | +14.0% | 0.01% | +8.3% |
| Q1 2021 | $582,000 | -56.3% | 7,810 | -0.1% | 0.01% | -58.6% |
| Q4 2020 | $1,333,000 | +22.7% | 7,821 | +1.1% | 0.03% | +7.4% |
| Q3 2020 | $1,086,000 | -12.8% | 7,733 | -0.5% | 0.03% | -15.6% |
| Q2 2020 | $1,246,000 | – | 7,772 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |